PLIVA, a Member of the Teva Group Tihomir Oreskovic President of the Management Board, Pliva Croatia Ltd. October, 2013 Croatia & SEE

About TEVA – Strong Foundations 111 years in existence $20.3B 2012 revenues $5.35 2012 EPS 73 manufacturing sites Over 46,000 employees 60 countries 70B tablets and capsules per annum 55,000+ SKUs 1,000 molecules Croatia & SEE 2

Core Strenghts Leading healthcare provider Balanced business model Manufacturing strengths Integrated R&D Entrepreneurial employees and culture Partnering experience Go-to-market capabilities 3 Croatia & SEE 3

PLIVA in Croatia – Pharma Leader in SEE PLIVA, a member of the Teva Group (since 2008). Established in 1921 The largest pharmaceutical company in Croatia and one of the leading pharma companies in SEE generics inovative products and therapies (Copaxone...) regional partnerships One of major exporters in Croatia >80% for export (30% Russia; 25% USA) 2000 employees in Croatia Croatia & SEE 4 4

Working from Croatia RUSSIA CANADA ASIA EU USA JAPAN LATAM SAR Over 60 locations worldwide Croatia & SEE

Croatia - Strategically Important Production Site for TEVA New investment cycle in production Teva is investing $200M+ in Croatia (2011 – 2014) Significant expansion of production capacities in Zagreb Construction of a new manufacturing plant and supporting facilities in Savski Marof Vertically integrated production highly sophisticated products FDA approved - regularly audited by the FDA (since 1965), EMEA and other Higly qualified employees Knowledge and best practice sharing Croatia & SEE

Operations Croatia Complying with the highest global quality standards Markets: US, EMIA, EU; >80% for export (30% Russia; 25% USA) $100M+ construction of Sterile and Oral Solid Forms facilities Technology driven manufacturing site Significantly increased production capacities 80% for exports Capacity 10B tabs Croatia & SEE 7

TAPI Croatia - World’s Largest AZI Supplier Chemical development center (98% for exports) Markets: US, EMIA, EU, JP, CA, LATAM $100M+ the construction of the state-of-the-art facilities Investment in integrated environmental protection ($20M) Supplying 90 % of AZI demand on regulated markets 100 % increase in production capacities Croatia & SEE

PLIVA’s R&D Center of Excellence R&D Croatia - holder of Teva's strategy for the development of complex products and NTEs 200+ highly skilled employees in R&D Experience and knowledge in development of complex projects Understanding of regulatory requirements: EU, US, CAN, EMIA, ASIA... One of the biggest users of the R&D tax incentives in Croatia Croatia & SEE

Beyond Production and R&D SSC Zagreb IT SSC Finance SSC Pharmakovigilance Communications Procuirment development Business Regulatory Quality Legal HR Regional & Global support Providing services to different sites/countries in EU, EMIA, Asia, Americas Croatia & SEE

Working with Croatian Companies – Capabilities, Potentials and Opportunities located in the heart of Central Europe the leading market for SEE region, highly skilled and educated people average salaries below the EU average EU member July 2013 Competitive incentives, R&D, employment capital Croatia & SEE

Thank you!